文献速递慢性肾脏病肾小球疾病

UACR与UPCR和肾衰竭的关联:临床试验汇总分析

Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该汇总分析纳入DAPA-CKD、EMPA-KIDNEY、RENAAL和IDNT四项CKD试验共6219例有UACR和UPCR数据的参与者,比较两者与肾衰竭的关联。结果显示UACR和UPCR均为强预测因子,但UACR关联更强(汇总HR 3.29 vs 2.89),总体相对比值比1.10支持UACR。

要点

  • UACR和UPCR每增加1个标准差均与肾衰竭强相关,但UACR预测性更优。
  • 在2型糖尿病合并CKD亚组中UACR优势更明显(RR 1.12)。
  • 肾小球疾病亚组中两者差异证据不明确(RR 0.97)。

核心结论

  • UACR和UPCR均是肾衰竭的稳健预测指标,但UACR的关联更强,尤其在糖尿病CKD人群中。

研究设计与样本

  • 对DAPA-CKD、EMPA-KIDNEY、RENAAL和IDNT四项CKD临床试验的个体参与者数据进行汇总分析,共纳入6219例有UACR和UPCR测量的CKD患者。

主要发现

  • 对数转换UACR每增加1个标准差的汇总HR为3.29(95%CI: 2.91, 3.72),UPCR为2.89(95%CI: 2.52, 3.32)。
  • UACR与UPCR的总体相对比值比为1.10(95%CI: 1.03, 1.18),支持UACR。
  • 2型糖尿病合并CKD亚组中相对比值比为1.12(95%CI: 1.04, 1.20)。
  • 肾小球疾病亚组中相对比值比为0.97(95%CI: 0.83, 1.13),差异证据不明确。

临床怎么用

  • 在CKD风险分层中,UACR应作为首选的尿液蛋白测量指标,尤其在糖尿病CKD患者中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Urinary albumin-to-creatinine ratio (UACR) and urinary protein-to-creatinine ratio (UPCR) are widely used markers for chronic kidney disease (CKD) risk stratification. While albuminuria is considered a sensitive predictor of kidney outcomes, proteinuria remains in use due to cost considerations or traditions. To assess their relative utility in prediction, we compared associations of UACR and UPCR with kidney failure in CKD clinical trials. We conducted a pooled analysis of individual participant-level data from four landmark CKD trials: DAPA-CKD, EMPA-KIDNEY, RENAAL, and IDNT. Overall, these trials included 6219 participants with CKD, with and without diabetes, with available UACR and UPCR measurements derived from spot or 24-h urine samples. Associations with kidney failure-defined as dialysis, transplantation, or sustained estimated glomerular filtration rate (eGFR) decline <15 or <10 ml/min/1.73 m2-were assessed using Cox proportional hazards models adjusted for demographic and clinical covariates. Hazard ratios (HRs) per standard deviation increase in log-transformed UACR and UPCR were compared using relative ratios (RRs) and pooled across trials using random-effects models. Across trials, both UACR and UPCR were strongly associated with kidney failure. Pooled HRs per standard deviation increment in log-transformed UACR or UPCR were 3.29 (95% CI: 2.91, 3.72) and 2.89 (95% CI: 2.52, 3.32), respectively, yielding an overall RR of 1.10 (95% CI: 1.03, 1.18), favouring UACR. This difference was clearest in the subgroup with type 2 diabetes and CKD (RR: 1.12; 95% CI: 1.04, 1.20), with less clear evidence for a difference among participants with glomerular disease (RR: 0.97; 95% CI: 0.83, 1.13). Both UACR and UPCR are robust predictors of kidney failure, but UACR demonstrated stronger associations, particularly in diabetic CKD. With a standardized urinary albumin assay becoming clinically available in 2027, these results support UACR as the preferred urinary protein measure for risk stratification.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Mepschen M, Vos R, Herrington W, et al. Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials. Nephrol Dial Transplant. 2026. PMID: 42029078. doi:10.1093/ndt/gfag081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。